Detection of minimal residual disease in bone marrow during or after therapy as a prognostic marker for high-risk neuroblastoma

J Pediatr Hematol Oncol. 2001 Mar-Apr;23(3):150-2. doi: 10.1097/00043426-200103000-00005.
No abstract available

MeSH terms

  • Bone Marrow Neoplasms / diagnosis*
  • Humans
  • Neoplasm, Residual
  • Neuroblastoma / diagnosis*
  • Neuroblastoma / therapy
  • Prognosis